Skip to main content
Log in

Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line’s supernatant via nuclear factor κB/Rel pathway

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To study the immunologic function of dendritic cells (DCs) cultured in two kinds of hepatoma cell line’s supernatant and the enhancing effects of carboxymethylpachymaran (CMP) on DCs.

Methods

DCs were harvested after stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 from umbilical cord blood using density-gradient centrifugation method. Cultured supernatant of two hepatoma cell lines (HepG2 and HepG2.2.15) were collected for condition medium (CM) according to a volume ratio of supernatant to incomplete RPMI-1640 medium, which was 3:1. CMP was dissolved in incomplete RPMI-1640 medium. Experimental groups were divided according to the culture medium, either CM or with CMP in it. DCs subsets CD83, CD86, CD1a, and d-related human leukocyte antigens (HLA-DR) were analyzed by flow cytometry. The proliferation ability of allogeneic T cells in mixed lymphocyte reaction (MLR) stimulated by DCs was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis. IL-12p70, interferon-γ (IFN-γ), and nuclear factor κB (NF-κB) were detected by enzyme-linked immunosorbent assay analysis.

Results

The proliferation of lymphocytes and secreting level of IL-12 and expression of phenotype of DCs cultured in two kinds of CM were lower than those of normal group (P <0.01). Compared with the normal group, groups treated with CMP showed a higher expression level of DCs subsets, lymphocyte reproductive activity, as well as IL-12 and IFN-γ secretion levels. Groups treated with CMP also demonstrated higher levels of DCs phenotype expression and IL-12 and IFN-γ secretion in supernatant of MLR and higher lymphocyte reproductive activity compared with CM group (P <0.05). Compared with the normal group, the expression level of NF-κB in DCs nuclear was higher in CMP groups but lower in two CM groups (P <0.05). After CMP was added, the NF-κB expression levels of two CM groups were increased compared with levels before CMP was added (P <0.05). However, there was no significant difference between the two CM groups (P >0.05).

Conclusions

Two kinds of hepatoma cell line’s supernatant can inhibit the immunologic function of DCs. This suppressive effect may be related to the inhibition of NF-κB/Rel pathway. CMP may up-regulate the DCs function by activating the NF-κB/Rel pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533–543.

    Article  PubMed  CAS  Google Scholar 

  2. Akbar FM, Horiike N, Onji M, Hino O. Dendritic cells and chronic hepatitis virus carriers. Intervirology 2001;44:199–208.

    Article  PubMed  CAS  Google Scholar 

  3. Qiu SJ, Lu L, Qiao C, Wang L, Wang Z, Xiao X, et al. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protin immunization. J Cancer Res Clin Oncol 2005;131:429–438.

    Article  PubMed  CAS  Google Scholar 

  4. Caux C, Liu YJ, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995;16:2–4.

    Article  PubMed  CAS  Google Scholar 

  5. Zhang YX, Zan YL, Shan M, Liu CM, Shi M, Li M, et al. Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expression. Biochem Biophys Communicat 2006;344:581–587.

    Article  CAS  Google Scholar 

  6. Eli Gilboa. How tumors escape immune destruction and what we can do about it. Cancer immunology, Immunotherapy 1999;48:382–385.

    Article  Google Scholar 

  7. Pardoll D. T cells and tumors. Nature 2001;411:1010–1012.

    Article  PubMed  CAS  Google Scholar 

  8. Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001;2:293–299.

    Article  PubMed  CAS  Google Scholar 

  9. Lee KY, Jeon YL. Polysaccharide isolated from poria cocos sclerotium induces NF-κB/Rel activation and iNOS expression in murine macrophages. Int Immunopharmacol 2003;3:1353–1362.

    Article  PubMed  CAS  Google Scholar 

  10. Qian S, Shi M, Zhang H, Zhang B, Xu DP, Wang FS. Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus antigens in patients with HBV-associated hepatocellular carcinoa. Nat Med J China (Chin) 2005;85:248–252.

    CAS  Google Scholar 

  11. Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol 2000;15:431–436.

    Article  PubMed  CAS  Google Scholar 

  12. Shi M, Qian S, Chen WW, Zhang H, Zhang B, Tang ZR, et al. Hepatitis B virus (HBV) antigen-pulsed monocytederived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 2006;147:277–286.

    Article  CAS  Google Scholar 

  13. Yu P, Spiotto MT, Lee Y, Schreiber H, Fu YX. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med 2003;197:985–995.

    Article  PubMed  CAS  Google Scholar 

  14. Cuenca A, Cheng F, Wang H, Brayer J, Horna P, Gu L, et al. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res 2003;63:9007–9015.

    PubMed  CAS  Google Scholar 

  15. Spiotto MT, Fu YX, Schreiber H. Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation. Curr Opin Immunol 2003;15:725–730.

    Article  PubMed  CAS  Google Scholar 

  16. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685–711.

    Article  PubMed  CAS  Google Scholar 

  17. Lu SC, Cao QL, Zhang L. Effect of pachymaran on immunologic function of normal and tumor-bearing mice. J First Milit Med Univ (Chin) 1990;10:267–268.

    Google Scholar 

  18. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071–5079.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiao-yin Chen  (陈孝银).

Additional information

Supported by the National Natural Science Foundation of China (No. 30973693) and the Research Fund for the Doctoral Program of Higher Education of China (No. 20104401110003)

These authors contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Z., Yu, B., Wu, Xl. et al. Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line’s supernatant via nuclear factor κB/Rel pathway. Chin. J. Integr. Med. 18, 203–208 (2012). https://doi.org/10.1007/s11655-011-0943-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-011-0943-4

Keywords

Navigation